Cargando…
From ERα66 to ERα36: a generic method for validating a prognosis marker of breast tumor progression
BACKGROUND: Estrogen receptor alpha36 (ERalpha36), a variant of estrogen receptor alpha (ER) is expressed in about half of breast tumors, independently of the [ER+]/[ER-] status. In vitro, ERalpha36 triggers mitogenic non-genomic signaling and migration ability in response to 17beta-estradiol and ta...
Autores principales: | Chamard-Jovenin, Clémence, Jung, Alain C., Chesnel, Amand, Abecassis, Joseph, Flament, Stéphane, Ledrappier, Sonia, Macabre, Christine, Boukhobza, Taha, Dumond, Hélène |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469423/ https://www.ncbi.nlm.nih.gov/pubmed/26080803 http://dx.doi.org/10.1186/s12918-015-0178-7 |
Ejemplares similares
-
Mammary epithelial cell phenotype disruption in vitro and in vivo through ERalpha36 overexpression
por: Thiebaut, Charlène, et al.
Publicado: (2017) -
Dual Epigenetic Regulation of ERα36 Expression in Breast Cancer Cells
por: Thiebaut, Charlène, et al.
Publicado: (2019) -
The Role of ERα36 in Development and Tumor Malignancy
por: Thiebaut, Charlène, et al.
Publicado: (2020) -
Low-Dose Alkylphenol Exposure Promotes Mammary Epithelium Alterations and Transgenerational Developmental Defects, But Does Not Enhance Tumorigenic Behavior of Breast Cancer Cells
por: Chamard-Jovenin, Clémence, et al.
Publicado: (2017) -
An Alkylphenol Mix Promotes Seminoma Derived Cell Proliferation through an ERalpha36-Mediated Mechanism
por: Ajj, Hussein, et al.
Publicado: (2013)